I alt havde 54% af patienterne en persisterende komplikation, 9% havde samtidig bakteriæmi, og 23% var inficeret med en levofloxacinresistent uropatogen ved baseline.
Overall, 54% of patients had a persistent complication, 9% had concurrent bacteraemia and 23% were infected with a levofloxacin resistant uropathogen at baseline.